Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)

Clinical Cancer Research

Saved in:

Bibliographic Details
Main Authors:	Zhou, S., Ching, L.-M., Baguley, B.C., Kestell, P., Palmer, B.D., Lu, J.
Other Authors:	PHARMACY
Format:	Others
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/106568
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-106568
record_format	dspace
spelling	sg-nus-scholar.10635-1065682015-01-26T18:07:37Z Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters) Zhou, S. Ching, L.-M. Baguley, B.C. Kestell, P. Palmer, B.D. Lu, J. PHARMACY Clinical Cancer Research 9 14 5429- CCREF 2014-10-29T02:01:53Z 2014-10-29T02:01:53Z 2003-11-01 Others Zhou, S.,Ching, L.-M.,Baguley, B.C.,Kestell, P.,Palmer, B.D.,Lu, J. (2003-11-01). Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters). Clinical Cancer Research 9 (14) : 5429-. ScholarBank@NUS Repository. 10780432 http://scholarbank.nus.edu.sg/handle/10635/106568 NOT_IN_WOS Scopus
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
description	Clinical Cancer Research
author2	PHARMACY
author_facet	PHARMACY Zhou, S. Ching, L.-M. Baguley, B.C. Kestell, P. Palmer, B.D. Lu, J.
format	Others
author	Zhou, S. Ching, L.-M. Baguley, B.C. Kestell, P. Palmer, B.D. Lu, J.
spellingShingle	Zhou, S. Ching, L.-M. Baguley, B.C. Kestell, P. Palmer, B.D. Lu, J. Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)
author_sort	Zhou, S.
title	Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)
title_short	Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)
title_full	Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)
title_fullStr	Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)
title_full_unstemmed	Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)
title_sort	correspondence re: j. lu et al., thalidomide metabolites in mice and patients with multiple myeloma. clin. cancer res., 9: 1680-1688, 2003 [1] (multiple letters)
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/106568
_version_	1681093488342466560

Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)

Similar Items